Back to search
FDAFDA · Food and drugs·Recall number D-1538-2022

Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00

Published September 21, 2022 · Recall initiated: September 15, 2022

Summary

FDA records drug Class II recall D-1538-2022, published September 21, 2022 and initiated September 15, 2022. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 1,699 blister cards/30 tablets each; Lot: Lot # J0636336-073022, J0637605-080422, Exp. date 08/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Distributed to two direct accounts in PA and AK.
Lot
Lot # J0636336-073022, J0637605-080422, Exp. date 08/31/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00 recalled?

Yes. FDA published recall D-1538-2022 on September 21, 2022. Reported hazard: Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

What should I do if I have this product?

Voluntary: Firm initiated · Letter